|
1.
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
|
|
2.
|
Gish RG and Baron A: Hepatocellular
carcinoma (HCC): current and evolving therapies. IDrugs.
11:198–203. 2008.PubMed/NCBI
|
|
3.
|
Konkimalla VB and Efferth T:
Evidence-based Chinese medicine for cancer therapy. J
Ethnopharmacol. 116:207–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Beinfield H and Korngold E: Chinese
medicine and cancer care. Altern Ther Health Med. 9:38–52.
2003.
|
|
5.
|
Huang CF, Lin SS, Liao PH, Young SC and
Yang CC: The immunopharmaceutical effects and mechanisms of herb
medicine. Cell Mol Immunol. 5:23–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Pan B, Cheng T, Nan KJ, Qiu GQ and Sun XC:
Effect of Fuzheng Yiliu decoction combined with chemotherapy on
patients with intermediate and late stage gastrointestinal cancer.
World J Gastroenterol. 11:439–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Yan Y, Cook J, McQuillan J, Zhang G,
Hitzman CJ, Wang Y, Wiedmann TS and You M: Chemopreventive effect
of aerosolized polyphenon E on lung tumorigenesis in A/J mice.
Neoplasia. 9:401–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Fang Y, Zhang Y, Chen M, Zheng H and Zhang
K: The active component of Hedyotis diffusa Willd. Chinese
Trad Plant Med. 26:577–579. 2004.
|
|
9.
|
Wu YG and Song LR: Shanghai Science and
Technology Press. Zhong hua ben cao (Chin). 25:530–533. 1998.
|
|
10.
|
Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu
ZZ, Su YT, Liao LM and Du J: Water extract of Hedyotis
Diffusa Willd suppresses proliferation of human HepG2 cells and
potentiates the anticancer efficacy of low-dose 5-fluorouracil by
inhibiting the CDK2-E2F1 pathway. Oncol Rep. 28:742–748. 2012.
|
|
11.
|
Lin J, Chen Y, Wei L, Chen X, Xu W, Hong
Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract
induces apoptosis via activation of the mitochondrion-dependent
pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338.
2010.
|
|
12.
|
Lin J, Wei L, Xu W, Hong Z, Liu X and Peng
J: Effect of Hedyotis Diffusa Willd extract on tumor
angiogenesis. Mol Med Rep. 4:1283–1288. 2011.
|
|
13.
|
Jitka P, Milan K and Jaromír S: Biological
activities of Prunella vulgaris extract. Phytother Res.
17:1082–1087. 2003.
|
|
14.
|
Psotova J, Svobodova A, Kolarova H and
Walterova D: Photoprotective properties of Prunella vulgaris
and rosmarinic acid on human keratinocytes. J Photochem Photobiol
B. 84:167–174. 2006.
|
|
15.
|
Hunter T and Pines J: Cyclins and cancer.
II: Cyclin D and CDK inhibitors come of age. Cell. 79:573–582.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Morgan DO: Principles of CDK regulation.
Nature. 374:131–134. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Cobrinik D: Pocket proteins and cell cycle
control. Oncogene. 24:2796–2809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Glotzer M: The molecular requirements for
cytokinesis. Science. 307:1735–1739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Tin AS, Sundar SN, Tran KQ, Park AH,
Poindexter KM and Firestone GL: Antiproliferative effects of
artemisinin on human breast cancer cells requires the downregulated
expression of the E2F1 transcription factor and loss of E2F1-target
cell cycle genes. Anticancer Drugs. 23:370–379. 2012. View Article : Google Scholar
|
|
20.
|
Fang XM, Liu B, Liu YB, Wang JJ, Wen JK,
Li BH and Han M: Acetylbritannilactone suppresses growth via
upregulation of krüppel-like transcription factor 4 expression in
HT-29 colorectal cancer cells. Oncol Rep. 26:1181–1187.
2011.PubMed/NCBI
|
|
21.
|
Chen LW, Lin J, Chen W and Zhang W: Effect
of Chinese herbal medicine on patients with primary hepatic
carcinoma in III stage during perioperational period: a report of
42 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:832–834. 2005.(In
Chinese).
|
|
22.
|
Chen L, Zheng C and Du J: Study on
antitumor mechanism of Qingre Xiaozheng drink by molecular docking
method. Clin Pharmacol Ther (Chin). 12:324–328. 2007.
|
|
23.
|
Li ZQ: Traditional Chinese medicine for
primary liver cancer. World J Gastroenterol. 4:360–364. 1998.
|
|
24.
|
Qui JX and Yang JK: Clinical observation
and experimental research in treatment of liver cancer at advanced
stage by traditional medication of strengthening the Spleen,
replenishing Qi, clearing away heat and toxic material. J
Integrated Trad Chin West Med. 7:275–277. 1987.
|
|
25.
|
Yadav SK and Lee SC: Evidence for
Oldenlandia diffusa-evoked cancer cell apoptosis through
superoxide burst and caspase activation. Zhong Xi Yi Jie He Xue
Bao. 4:485–489. 2006.
|
|
26.
|
Rasul A, Yu B, Yang LF, Ali M, Khan M, Ma
T and Yang H: Induction of mitochondria-mediated apoptosis in human
gastric adenocarcinoma SGC-7901 cells by kuraridin and
Nor-kurarinone isolated from Sophora flavescens. Asian Pac J
Cancer Prev. 12:2499–2504. 2011.PubMed/NCBI
|
|
27.
|
Lin CC and Namba T: Historical and
herbological studies on the traditional Japanese and Chinese crude
drugs. On the ‘Shān-cí-gū’. Yakushigaku Zasshi. 20:88–98. 1985.(In
Japanese).
|
|
28.
|
Nigg EA: Cyclin-dependent protein kinases:
key regulators of the eukaryotic cell cycle. Bioessays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Orlando DA, Lin CY, Bernard A, Wang JY,
Socolar JES, Iversen ES, Hartemink AJ and Haase SB: Global control
of cell-cycle transcription by coupled CDK and network oscillators.
Nature. 453:944–947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Feng L, Jia XB, Shi F and Chen Y:
Identification of two polysaccharides from Prunella vulgaris
L and evaluation on their anti-lung adenocarcinoma activity.
Molecules. 15:5093–5103. 2010.
|
|
31.
|
Kang SC, Lee CM, Choi H, Lee JH, Oh JS,
Kwak JH, Lee JH, Oh JS, Kwak JH and Zee OP: Evaluation of oriental
medicinal herbs for estrogenic and antiproliferative activities.
Phytother Res. 20:1017–1019. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Zhang Z, Wang X, Wu W, Wang J, Wang Y, Wu
X, Fei X, Li S, Zhang J, Dong P, Gu J and Liu Y: Effects of matrine
on proliferation and apoptosis in gallbladder carcinoma cells
(GBC-SD). Phytother Res. 26:932–937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Zhang P, Wang Z, Chong T and Ji Z: Matrine
inhibits proliferation and induces apoptosis of the
androgen-independent prostate cancer cell line PC-3. Mol Med Rep.
5:783–787. 2012.PubMed/NCBI
|
|
34.
|
Qin XG, Hua Z, Shuang W, Wang YH and Cui
YD: Effects of matrine on HepG2 cell proliferation and expression
of tumor relevant proteins in vitro. Pharm Biol. 48:275–281. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Zhao B, Li B, Bai S, Shen L, Ren R, Jonas
JB, Xu X, Lu Q and Liu Q: Effects of matrine on proliferation and
apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp
Ophthalmol. 250:897–905. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Agami R and Bernards R: Convergence of
mitogenic and DNA damage signaling in the G1 phase of the cell
cycle. Cancer Lett. 177:111–118. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Brew CT, Aronchik I, Hsu JC, Sheen JH,
Dickson RB, Bjeldanes LF and Firestone GL: Indole-3-carbinol
activates the ATM signaling pathway independent of DNA damage to
stabilize p53 and induce G1 arrest of human mammary epithelial
cells. Int J Cancer. 118:857–868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Alpan RS and Pardee AB: p21WAF1/CIP1/SDI1
is elevated through a p53-independent pathway by mimosine. Cell
Growth Differ. 7:893–901. 1996.PubMed/NCBI
|
